Skip to content

Sana Biotechnology SANA Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$47.21M+4.4%-$58.83M-19.9%-$42.15M+29.7%-$93.8M-86.5%-$49.39M+54.0%
$2.39M-34.5%$3.2M-22.0%$2.9M-25.6%$3.65M-2.6%
$5.66M-19.4%$6.34M-1.5%$5.48M-49.2%$6.63M-41.7%$7.02M-22.8%
-$37.38M+23.2%-$32.64M+30.8%-$29.43M+43.2%-$33.1M+43.5%-$48.66M+25.9%
$288K+112%$873K+100%$41K-99.0%$136K-99.1%
$49.44M+198%-$16.5M-135%-$48.03M$7.68M$16.6M+121%
-$128K-113%$17.65M+2,645%$109.54M+5,161%$561K-94.7%$982K-99.5%
$11.93M+138%-$31.49M-$24.86M-$31.07M-171%
-$37.67M+22.8%-$33.51M+29.6%-$29.47M+47.3%-$32.99M+53.9%-$48.79M+40.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Sana Biotechnology generate?
Sana Biotechnology (SANA) generated -$132.6M in operating cash flow over the trailing twelve months.
What is Sana Biotechnology's free cash flow?
After $1.3M of capital expenditures, Sana Biotechnology's free cash flow was -$133.6M over the trailing twelve months, up 40.3% year over year.
Where does Sana Biotechnology's cash flow data come from?
Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.